| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ... Clinical infectious diseases 46 (3), 327-360, 2008 | 3631 | 2008 |
| Epidemiology and outcome of zygomycosis: a review of 929 reported cases MM Roden, TE Zaoutis, WL Buchanan, TA Knudsen, TA Sarkisova, ... Clinical infectious diseases 41 (5), 634-653, 2005 | 3542 | 2005 |
| Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ... Clinical infectious diseases 63 (4), e1-e60, 2016 | 3033 | 2016 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 2204 | 2020 |
| Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection … DP Kontoyiannis, KA Marr, BJ Park, BD Alexander, EJ Anaissie, TJ Walsh, ... Clinical Infectious Diseases 50 (8), 1091-1100, 2010 | 1673 | 2010 |
| Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) PG Pappas, BD Alexander, DR Andes, S Hadley, CA Kauffman, A Freifeld, ... Clinical Infectious Diseases 50 (8), 1101-1111, 2010 | 1651 | 2010 |
| Epidemiology and clinical manifestations of mucormycosis G Petrikkos, A Skiada, O Lortholary, E Roilides, TJ Walsh, ... Clinical Infectious Diseases 54 (suppl_1), S23-S34, 2012 | 1639 | 2012 |
| Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled … JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ... The Lancet 387 (10020), 760-769, 2016 | 941 | 2016 |
| Pathogenesis of mucormycosis AS Ibrahim, B Spellberg, TJ Walsh, DP Kontoyiannis Clinical infectious diseases 54 (suppl_1), S16-S22, 2012 | 897 | 2012 |
| Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis G Chamilos, RE Lewis, DP Kontoyiannis Clinical Infectious Diseases 47 (4), 503-509, 2008 | 873 | 2008 |
| Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases DP Kontoyiannis, MS Lionakis, RE Lewis, G Chamilos, M Healy, ... The Journal of infectious diseases 191 (8), 1350-1360, 2005 | 780 | 2005 |
| Glucocorticoids and invasive fungal infections MS Lionakis, DP Kontoyiannis The Lancet 362 (9398), 1828-1838, 2003 | 767 | 2003 |
| Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases JAH van Burik, RS Hare, HF Solomon, ML Corrado, DP Kontoyiannis Clinical Infectious Diseases 42 (7), e61-e65, 2006 | 750 | 2006 |
| Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003) G Chamilos, M Luna, RE Lewis, GP Bodey, R Chemaly, JJ Tarrand, ... haematologica 91 (7), 986-989, 2006 | 669 | 2006 |
| Zygomycosis in the 1990s in a tertiary-care cancer center DP Kontoyiannis, VC Wessel, GP Bodey, KVI Rolston Clinical Infectious Diseases 30 (6), 851-856, 2000 | 646 | 2000 |
| Recent advances in the management of mucormycosis: from bench to bedside EJC Goldstein, B Spellberg, TJ Walsh, DP Kontoyiannis, J Edwards Jr, ... Clinical Infectious Diseases 48 (12), 1743-1751, 2009 | 622 | 2009 |
| Antifungal drug resistance of pathogenic fungi DP Kontoyiannis, RE Lewis The Lancet 359 (9312), 1135-1144, 2002 | 607 | 2002 |
| Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program J Morgan, KA Wannemuehler, KA Marr, S Hadley, DP Kontoyiannis, ... Medical mycology 43 (Supplement_1), S49-S58, 2005 | 554 | 2005 |
| Combination antifungal therapy for invasive aspergillosis: a randomized trial KA Marr, HT Schlamm, R Herbrecht, ST Rottinghaus, EJ Bow, OA Cornely, ... Annals of internal medicine 162 (2), 81-89, 2015 | 547 | 2015 |
| When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis TM John, CN Jacob, DP Kontoyiannis Journal of fungi 7 (4), 298, 2021 | 518 | 2021 |
